Gamma-oryzanol alleviates osteoarthritis development by targeting Keap1–Nrf2 binding to interfere with chondrocyte ferroptosis

已完结 10 由素年锦时发布于 2024/5/18 10:20:37

DOI:10.1016/j.intimp.2023.111469
作者：Zi-Han Dai 1, Chen-Cheng Zhou 2, Cai-Yu Yu 2, Cheng-Jie Qian 3, Shu-Qing Jin 2, Shi-Qi Du 2, Yi-Yun Lv 2, Chen Jin 4, Gang Zheng 5, Yu Zhan 6
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.intimp.2023.111469

Elsevier

Abstract：Osteoarthritis (OA) is a prevalent joint disorder pathologically correlated to chondrocyte ferroptosis. Gamma-oryzanol (γ-Ory), as a first-line drug for autonomic disorders, aroused our inte

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierRuscogenin attenuates cartilage destruction in osteoarthritis through suppressing chondrocyte ferroptosis via Nrf2/SLC7A11/GPX4 signaling pathway